SCHEMBL7985404

SCHEMBL7985404

CC(C)c1nc(O)c2c(ncn2Cc2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.49
SMN1; SMN2 Q16637 5/20 0.44
ALDH1A1 P00352 2/20 0.44
GAA P10253 2/20 0.41
KMT2A Q03164 2/20 0.41
PDE1A P54750 2/20 0.40
PDE1B Q01064 2/20 0.40
PDE1C Q14123 2/20 0.40
ADORA2B P29275 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
PKM P14618 2/20 0.40
MEN1 O00255 1/20 0.40
HTT P42858 1/20 0.40
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
TNF P01375 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
PARN O95453 1/20 0.39
CNOT7 Q9UIV1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974024 0.85 HPGD (0.46) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7975252 0.80 HPGD (0.45) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7989407 0.79 HPGD (0.44) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7985325 0.79 HPGD (0.42) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7975267 0.78 SMN1; SMN2 (0.46) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7985471 0.78 HPGD (0.43) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7989566 0.78 HPGD (0.41) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7988099 0.77 SMN1; SMN2 (0.45) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7984365 0.77 HPGD (0.45) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7985343 0.77 GAA (0.44) HPGDSMN1; SMN2ALDH1A1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed